T1	Participants 383 399	patients with HF
T2	Participants 496 584	1457 patients enrolled in the Controlled Rosuvastatin Multinational Trial in HF (CORONA)
T3	Participants 589 655	1233 patients enrolled in the GISSI-Heart Failure trial (GISSI-HF)
